# Bupivacaine

## Marcaine Spinal 0.5% 4mL inj (麻醉科用)

##### 

| TAH Drug Code      | IMAR4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Spinal anaesth for surgery.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Dosing             | Marcaine Spinal 0.5% contains bupivacaine 5mg/mL, 4mL/ampoule. Intrapinal injection. Spinal injections should only be made after the subarachnoid space has been clearly identified by lumbar puncture. No drug should be injected until clear cerebrospinal fluid (CSF) is seen to escape from the spinal needle or it is detected by aspiration. The dose required for the most effective blocking (patient in the supine horizontal position): For lower limbs, urinary tract and perineum surgery: 10-15 mg inject into L3/4/5. For hip and lower abdomen surgery: 15-20 mg and inject into L2/3/4. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Diseases of the cerebrospinal system; septicaemia; pernicious anemia with cord symptoms; cardiac decompensation; massive pleural effusions & markedly increased intra-abdominal pressure; pyogenic infection of skin.                                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | Drowsiness, unconsciousness, respiratory arrest; hypotension, myocardial depression, bradycardia, possibly cardiac arrest; numbness of the tongue, light-headedness, dizziness, tremor followed by convulsions may rarely occur.                                                                                                                                                                                                                                                                                                                                                                        |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

## Marcaine Spinal 0.5% Heavy inj 4mL

##### 

| TAH Drug Code      | IMARS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Spinal anaesth for surgery.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | Marcaine Spinal 0.5% Heavy contains bupivacaine 5mg/mL, 4mL/ampoule (with glucose monohydrate to adjust a specific gravity of 1.026 at 20°C). Intrapinal injection. Spinal injections should only be made after the subarachnoid space has been clearly identified by lumbar puncture. No drug should be injected until clear cerebrospinal fluid (CSF) is seen to escape from the spinal needle or it is detected by aspiration. The dose required for the most effective blocking: For lower limbs, urinary tract and perineum surgery (patient in the sitting position): 7.5-15 mg inject into L3/4/5. For lower abdomen surgery (patient in the supine horizontal position): 15-20 mg and inject into L2/3/4. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Acute active disease of the CNS, such as meningitis, tumours, poliomyelitis & cranial haemorrhage, active TB or metastatic lesions in the vertebral column. Septicaemia. Pernicious anaemia with subacute combined degeneration of the spinal cord. Pyrogenic infection of the skin at or adjacent to the site of puncture. Cardiogenic or hypovolaemic shock. Coagulation disorders or ongoing anticoagulant treatment.                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | Hypotension, bradycardia, post-spinal headache. Rarely, high or total spinal blockade resulting in CV & respiratory depression, neurological complications.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

